EP Patent

EP2600837A1 — Use of glyceryl trinitrate for treating hematomas

Assigned to G Pohl Boskamp GmbH and Co KG · Expires 2013-06-12 · 13y expired

What this patent protects

Use of glyceryl trinitrate (GTN) for treating hematomas.

USPTO Abstract

Use of glyceryl trinitrate (GTN) for treating hematomas.

Drugs covered by this patent

Patent Metadata

Patent number
EP2600837A1
Jurisdiction
EP
Classification
—
Expires
2013-06-12
Drug substance claim
No
Drug product claim
No
Assignee
G Pohl Boskamp GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.